Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
06/02/1999 | EP0918750A1 New guanidine derivatives, methods of preparing them and their use as drugs |
06/02/1999 | EP0918747A1 INHIBITORS OF THE PRODUCTION OF s-CD23 AND THE SECRETION OF TNF |
06/02/1999 | EP0918746A1 Immunotherapeutic agents and their use in the reduction of cytokine levels |
06/02/1999 | EP0918742A1 Water-miscible esters of monoglycerides having antimicrobial activity |
06/02/1999 | EP0918544A2 Polymer bile acid resorption inhibitors with simultaneous bile acid adsorbing effect |
06/02/1999 | EP0918542A2 Use of (meth)acrylic acid copolymers to increase the permeability of mucous membranes |
06/02/1999 | EP0918540A1 Intradermal bovine polynucleotide vaccine |
06/02/1999 | EP0918539A1 Vaccine for b-cell malignancies |
06/02/1999 | EP0918532A1 A novel method of detecting and treating cancer |
06/02/1999 | EP0918527A1 Deoxy and oxygen-substituted sugar-containing 14-aminosteroid compounds for use as an antiarrhythmic |
06/02/1999 | EP0918526A1 Bismuth salt of sialyloligosaccharide and a method for treating and inhibiting gastric and duodenal ulcers with same |
06/02/1999 | EP0918525A1 Use of mifepristone for the treatment of psychoses and addictive behaviours |
06/02/1999 | EP0918524A1 Mixed chimerism and tolerance |
06/02/1999 | EP0918523A1 Treatment of arthritis disorders, rheumatoid arthritis and manifestations associated with rheumatoid disorders |
06/02/1999 | EP0918522A1 Antagonists of gonadotropin releasing hormone |
06/02/1999 | EP0918521A1 Formulation for the treatment and/or prophylaxis of dementia |
06/02/1999 | EP0918520A1 Process for preparing potassium clavulanate |
06/02/1999 | EP0918519A1 Therapeutic treatment for vegf related occular diseases |
06/02/1999 | EP0918518A1 Treatment of mood/affective disorders by glutamatergic upmodulators |
06/02/1999 | EP0918517A1 Composition of micro-organisms containing omega-3-fatty acid useful as a prophylactic or therapeutic agent against parasitary diseases of animals |
06/02/1999 | EP0918516A1 Methods of preventing skeletal problems in poultry |
06/02/1999 | EP0918515A2 USE OF INHIBITORS OF THE CELLULAR Na?+ /H?+ EXCHANGER (NHE) FOR PREPARING A MEDICAMENT FOR NORMALIZING SERUM LIPIDS |
06/02/1999 | EP0918514A1 Triaryl methane compounds for sickle cell disease |
06/02/1999 | EP0918510A1 Bioadhesive complexes of polycarbophil and azole antifungal or antiprotozoal drugs |
06/02/1999 | EP0918504A2 Genistein as a preventive against ultraviolet induced skin photodamage and cancer |
06/02/1999 | EP0918469A1 Methods and compositions for increasing the anaerobic working capacity in tissues |
06/02/1999 | EP0918461A1 Methods of treating asthma with o-desulfated heparin |
06/02/1999 | EP0918460A1 Methods of treatment of eye trauma and disorders |
06/02/1999 | EP0918458A1 Antimicrobial treatment for herpes simplex virus and other infectious diseases |
06/02/1999 | EP0848607B1 Pharmaceutical compositions and devices for their administration |
06/02/1999 | EP0845036B1 Functional role of adrenomedullin (am) and the gene-related product (pamp) in human pathology and physiology |
06/02/1999 | EP0757718A4 Methods of use of uncoated gel particles |
06/02/1999 | EP0748310B1 Diesters of carbonic acid endowed with antiviral and anti-inflammatory activity |
06/02/1999 | EP0691849B1 Oesteoblast growth stimulating compostion containing pdgf and vitamin d |
06/02/1999 | EP0630376B1 Condensed indole derivatives as 5-ht4-receptor antagonists |
06/02/1999 | EP0625138B1 Novel amidine derivatives, their preparation and their use as medicaments with ltb4 antagonistic effect |
06/02/1999 | EP0593692B1 Process for the preparation of ergoline derivatives |
06/02/1999 | EP0581939B1 N-sulphonyl-2-oxoindole derivatives having affinity for vasopressin and/or ocytocin receptors |
06/02/1999 | EP0579766B1 N-arylheteroarylalkyl imidazol-2-one compounds for treatment of circulatory disorders |
06/02/1999 | EP0579681B1 Crystalline tiagabine hydrochloride monohydrate, its preparation and use |
06/02/1999 | EP0548254B1 6- or 7-(imidazolidin-2-ylideneamino)-1,4-benzoxazines as alpha adrenergic agents |
06/02/1999 | DE19900421A1 Viscoelastic solution for use in eye surgery |
06/02/1999 | DE19753298A1 Verfahren zur Herstellung von festen Dosierungsformen A process for the preparation of solid dosage forms |
06/02/1999 | DE19752952A1 Thienopyrimidine Thienopyrimidines |
06/02/1999 | CN1218512A Recombinant adenoviral vectors for human tumour gene therapy |
06/02/1999 | CN1218478A Cyclic adhesion inhibitors |
06/02/1999 | CN1218475A Taxane derivatives preparation thereof and formulation containing them |
06/02/1999 | CN1218474A Camptothecin-skeleton compounds isolated from mappia foetida and use thereof as syntones for medicaments as well as therapeutical agents |
06/02/1999 | CN1218473A Naphthyridine derivatives and their analogues inhibiting cytomegalovirus |
06/02/1999 | CN1218472A Pharmaceutically useful compounds |
06/02/1999 | CN1218471A Carboline derivatives |
06/02/1999 | CN1218467A Sulphur derivatives comprising amide bond, method for preparing same, use thereof as drugs, and pharmaceutical compositions containing such derivatives |
06/02/1999 | CN1218466A 2,4-diaminopyrimidine derivatives as dopamine d4 receptor antagonists |
06/02/1999 | CN1218465A 2,4-diaminopyrimidine derivatives |
06/02/1999 | CN1218464A 2,3 disulbstituted-4 (3H)-quinazolinones |
06/02/1999 | CN1218463A Asymmetric synthesis of R-'alpha'-propyl-piperonyl amine and its analogs |
06/02/1999 | CN1218462A Crystalline (-)-3R, 4R-trans-7-methoxy-2,2-dimetnyl-3-phenyl-4-{4-[2-(pyrrolidin-1-yl) ethoxy] phenyl} chromane, hydrogen fumarate |
06/02/1999 | CN1218461A Alkylaminobenzothiazole and -benzoxazole derivatives |
06/02/1999 | CN1218460A Substituted 4-hydroxy-phenylalcanoic acid derivatives with activity to ppar-'gamma' |
06/02/1999 | CN1218459A 2-(3H)-oxazolene derivatives and their use as cox-2 inhibitors |
06/02/1999 | CN1218456A Irreversible inhibitors of tyrosine kinases |
06/02/1999 | CN1218411A Method of killing target cells in harvested cell populations |
06/02/1999 | CN1218410A Use of IL-12 and IFN-'alpha' for treatment of infections diseases |
06/02/1999 | CN1218409A Stimulation of host defence mechanisms against viral challenges |
06/02/1999 | CN1218405A Treatment of cystic disease with TNF-'alpha' |
06/02/1999 | CN1218403A Formulation for use in prevention of pathogen induced diseases including HIV and HSV |
06/02/1999 | CN1218402A Improvement of implantation rates after vitro fertilization |
06/02/1999 | CN1218401A Treatment of asthma and airway diseases |
06/02/1999 | CN1218400A Cyclopentane heptan(ene) oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
06/02/1999 | CN1218399A Benzamide treatment of dementia associated with AIDs virus (HIV-4) infection |
06/02/1999 | CN1218398A Proopofol microdroplet formulations |
06/02/1999 | CN1218397A Ethene containing solutions and use thereof in methods of therapy or prophylaxis |
06/02/1999 | CN1218395A Buccal delivery system |
06/02/1999 | CN1218394A Dispersible macromolecule compositions and methods for their preparation and use |
06/02/1999 | CN1218387A Cosmetic composition for rejuvenation of skin without skin irratation |
06/02/1999 | CN1218368A Method for treating common cold or allergic rhinitis |
06/02/1999 | CN1218056A Transdeoxyoilnucleotide for inhibiting replication of hepatitis B virus |
06/02/1999 | CN1218052A New indole and indazole compounds, process for their preparation and pharmaceutical compositions containing them |
06/02/1999 | CN1218051A New 2,3-dioxide, indanol compounds, process for their preparation and pharmaceutical compositions containing them |
06/02/1999 | CN1218050A Sulfonamide-substituted benzopyran derivates processes for their preparation, their use as medicament, and pharmaceutical preparations comprising them |
06/02/1999 | CN1218049A Chromene derivatives and salts thereof, and pharmaceuticals containing the same |
06/02/1999 | CN1218047A Novel imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them |
06/02/1999 | CN1218046A Imide derivatives |
06/02/1999 | CN1218045A Imide derivatives or salts thereof |
06/02/1999 | CN1218044A Urea derivatives |
06/02/1999 | CN1218043A Preparation and use of selenium substituted chromium methionine |
06/02/1999 | CN1217915A Preparing method for Xiaozhangming eye drops |
06/02/1999 | CN1217914A Preparation and process for increasing solubility of Awei antibiotics |
06/02/1999 | CN1217913A Composition containing vitamin A acid and clindamycin for treating acne |
06/02/1999 | CN1217912A Composite rifapentine preparation and preparing method therefor |
06/02/1999 | CN1043532C The sulphate salt of a substituted triazole, pharmaceutical compositions thereof, and their use in therapy |
06/02/1999 | CN1043531C Pyrimidine derivatives and a process for production thereof |
06/02/1999 | CN1043528C Method for preparation of taxol using an oxazinone |
06/02/1999 | CN1043527C Improvements in and relating to guantidine derivatives |
06/02/1999 | CN1043526C Sulfoneanilide derivative and application of same in medicine |
06/02/1999 | CN1043509C Antioxidant cardioprotective use of and method of treatment using, hydroxycarbazole compounds |
06/02/1999 | CN1043508C Process for preparing liquid pharmaceutical composition for controlling release treatment system |
06/01/1999 | US5909099 Electric vehicle charging system including refrigerant system |
06/01/1999 | US5908940 Processes for recovering tocotrienols, tocopherols and tocotrienol-like compounds |
06/01/1999 | US5908933 Certain 4H- 1!benzopyrano 3,4-b!pyridine derivatives and their corresponding 6,7-b! and 7,8-b! ring isomers |